Federal Reserve moves up timeline for interest rate hikes, Delta strain officially a “variant of concern,” Biden wraps up Putin summit, and other news to start your day.
BP made a profit of $7.8bn in the first six months of 2021, compared to a loss of $21.2bn in the first half of 2020.
Every investor wants an ‘in,’ some hint that will tell exactly what a stock is going to do, and when. The kind of signal that will cut through the market’s noise, and makes sense of the deluge of raw data that every company generates. Multiply that data by 10,000 publicly traded stocks, and you’ll have some idea of just how daunting the markets can be. It’s tempting to follow an expert: a Wall Street analyst, or a trading guru. They all have important contributions to make. But here, we’ll take
QuantumScape founder and CEO Jagdeep Singh tells Yahoo Finance Live he is confident in hitting key production timelines.
Ocugen's stock price has soared by more than 260% in 2021, while the S&P 500 is up just 17%. The increase has been fueled by the hope that Covaxin, the COVID-19 vaccine candidate Ocugen is co-developing with India's Bharat Biotech, will lead to significant revenue for the healthcare company. The good news is that results look promising -- Ocugen reported in July that phase 3 results showed Covaxin to be over 93% effective in preventing severely symptomatic cases of COVID-19.
In 2019 and 2020, Pfizer's (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. The COVID-19 vaccine BNT162b2, developed by Pfizer and BioNTech (NASDAQ:BNTX), generated sales of $7.8 billion in the first half of 2021 alone. Pfizer expects the vaccine will rake in $33.5 billion over the entire year.
(Bloomberg) -- Sanofi will buy its messenger-RNA development partner Translate Bio Inc. for $3.2 billion as the French drugmaker plays catch-up in deploying the technology behind some of the world’s top-selling Covid-19 vaccines.Sanofi agreed to pay $38 in cash for each of Translate Bio’s shares. While the price is 30% above Monday’s closing price, the company is getting a potential bargain “in a very hot therapeutic area,” said Wimal Kapadia, an analyst at Bernstein.Ordinarily a giant in the va
Jay Jacobs, SVP and Head of Research & Strategy at Global X ETFs, joined Yahoo Finance to discuss Square’s acquisition of Afterpay.
(Bloomberg) -- Kiyoshi Matsuura was so worried about growing old that he started using an anti-baldness treatment as a teenager.It was an obsession that went on to define his life. The Japanese entrepreneur continued to experiment with various supplements and other products, and founded his own company dedicated to fighting the ravages of time about 12 years ago.Premier Anti-Aging Co. went public in Tokyo in October and quickly became one of Japan’s best-performing stocks. It’s more than tripled
GE's turnaround is gaining traction as key businesses improve while the industrial giant continues to shrink its debt load.
COVID-19 helped boost sales, but investors have to be confident the company can still thrive once the pandemic is over.
Hundreds of Chinese companies are listed on U.S. markets. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity. Often dozens of Chinese stocks are among the top performers at any given time, across an array of sectors.
In this article, we discuss the 10 best high short interest stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best High Short Interest Stocks to Buy Now. Stocks with high short interest have dominated the headlines in the finance world for a good […]
August is feared as one of the worst months for the S&P 500 — and for good reason. But investors still find ways to make big money.
Memory chip maker Micron Technology Inc on Monday said it would shift how it returns cash to shareholders, buying up more shares when prices are low, fewer when prices are high and instituting a dividend for the first time. This can cause swings in profits - and share prices - at most memory makers. Micron on Monday said it would start adjusting its previously regular share repurchases - which have returned about $4 billion in cash to shareholders since 2018 - to match those cycles, holding back when prices are high so that it can retire more shares for each dollar spent.
The oil giant has pledged more dividend rises and share buybacks of around £720 million a quarter until 2025 as oil prices bounce back.
Many investors are so focused on accumulating wealth that they neglect the second part of the equation.
(Bloomberg) -- BP Plc followed its Big Oil peers by increasing dividends and share buybacks as higher crude prices boosted profit.The oil majors -- with the notable exception of Exxon Mobil Corp. -- are raising returns as they express confidence that the worst of the slump caused by the coronavirus pandemic is over. Their goal is to woo investors who are becoming increasingly wary about the future of the fossil fuels in a changing climate.BP will increase its dividend by 4% to 5.46 cents a share
(Bloomberg) -- Tencent Holdings Ltd. led a stocks rout after Chinese state media decried the “spiritual opium” of games, prompting the company to broach a ban for kids and triggering fears Beijing will set its sights next on the world’s largest gaming arena.China’s most valuable corporation joined rivals from NetEase Inc. to Nexon Co. in a gaming selloff after an outlet run by the Xinhua News Agency published a blistering critique of their industry. The Economic Information Daily cited a student
A Relative Strength Rating upgrade for Advanced Micro Devices shows improving technical performance.
A second-quarter earnings report reminded investors how difficult it is for independent companies to launch new cancer drugs.